Retinal blood flow reduction after panretinal photocoagulation in Type 2 diabetes mellitus: Doppler optical coherence tomography flowmeter pilot study

PLoS One. 2018 Nov 8;13(11):e0207288. doi: 10.1371/journal.pone.0207288. eCollection 2018.

Abstract

To use a Doppler optical coherence tomography (DOCT) flowmeter to investigate segmental retinal blood flow (RBF) and sum of the segmental RBFs (SRBF) changes after panretinal photocoagulation (PRP) was used to treat type 2 diabetes mellitus with severe diabetic retinopathy (DR). Data from five patients with proliferative DR (PDR) (mean age 51.9 ± 10.5 years) was analyzed. The vessel diameter (D), average velocity (V), and retinal blood flow (RBF) in veins were measured using a DOCT flowmeter before and four weeks after PRP. Segmental RBF from inferotemporal (IT), superotemporal (ST), inferonasal (IN), and superonasal (SN) veins were measured, and SRBF was defined as the sum of these measurements. All data were analyzed by Wilcoxson test. After PRP, there were statistically significant decreases in the every segmental D, V, RBF (P<0.03) and SRBF (P = 0.002). The other parameters showed no statistically significant differences (P>0.05). The DOCT flowmeter has the potential to be a clinically useful tool to noninvasively evaluate the changes in retinal circulation during PRP in patients with PDR.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Flow Velocity
  • Diabetes Mellitus, Type 2* / diagnostic imaging
  • Diabetes Mellitus, Type 2* / physiopathology
  • Diabetes Mellitus, Type 2* / therapy
  • Diabetic Retinopathy* / diagnostic imaging
  • Diabetic Retinopathy* / physiopathology
  • Diabetic Retinopathy* / therapy
  • Female
  • Humans
  • Light Coagulation*
  • Male
  • Middle Aged
  • Pilot Projects
  • Retina* / diagnostic imaging
  • Retina* / physiopathology
  • Retinal Vessels* / diagnostic imaging
  • Retinal Vessels* / physiopathology
  • Tomography, Optical Coherence*

Grants and funding

The funder (Topcon Corporation) provided support in the form of salaries for author [MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author is articulated in the ‘author contributions’ section.